title: M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
authors.affiliation: Memorial Sloan-Kettering Cancer Center, New York, New York.
authors.forename: C N
authors.initials: CN
authors.lastname: Sternberg
authors.forename: A
authors.initials: A
authors.lastname: Yagoda
authors.forename: H I
authors.initials: HI
authors.lastname: Scher
authors.forename: W F
authors.initials: WF
authors.lastname: Whitmore
authors.forename: H W
authors.initials: HW
authors.lastname: Herr
authors.forename: M J
authors.initials: MJ
authors.lastname: Morse
authors.forename: P C
authors.initials: PC
authors.lastname: Sogani
authors.forename: R C
authors.initials: RC
authors.lastname: Watson
authors.forename: P S
authors.initials: PS
authors.lastname: Hollander
authors.forename: W R
authors.initials: WR
authors.lastname: Fair
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009362:Neoplasm Metastasis; D014481:United States; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D014747:Vinblastine; D004317:Doxorubicin; D002945:Cisplatin; D008727:Methotrexate